* Amphastar Pharmaceuticals Inc AMPH.OQ reported quarterly
adjusted earnings of 88 cents per share for the quarter ended
in December, higher than the same quarter last year, when the
company reported EPS of 73 cents. The mean expectation of
five analysts for the quarter was for earnings of 93 cents per
share. Wall Street expected results to range from 88 cents
to $1.00 per share.
* Revenue rose 31.9% to $178.11 million from a year ago;
analysts
expected $175.49 million.
* Amphastar Pharmaceuticals Inc's reported EPS for the
quarter was
68 cents.
* The company reported quarterly net income of $36.17
million.
* Amphastar Pharmaceuticals Inc shares had fallen by 24.7%
this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 1.8%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $68.00
This summary was machine generated from LSEG data March 1 at
05:19 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 0.93 0.88 Missed
Sep. 30 2023 0.69 1.15 Beat
Jun. 30 2023 0.56 0.65 Beat
Mar. 31 2023 0.48 0.62 Beat